Epithelial Cell-dependent Activation of Human Basophils
人类嗜碱性粒细胞的上皮细胞依赖性激活
基本信息
- 批准号:9179854
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-15 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:A549AddressAffectAffinityAgonistAllergensAllergicAllergic DiseaseAntibodiesAntigensAsthmaAtopic DermatitisBasophilsBindingBiological AssayCell CommunicationCell LineCellsCellular StructuresChildCoculture TechniquesConnective Tissue CellsDataDependencyDisease susceptibilityEpithelial CellsEpitheliumFibroblastsFoodGalectin 3HistamineHistamine ReleaseHumanHypersensitivityIgEIgE ReceptorsImmuneImmune responseInflammationInflammation MediatorsInterleukin-13Interleukin-3Interleukin-4KineticsLaboratoriesLearningLeukocytesLeukotriene C4LinkLungMediatingMediator of activation proteinMusNatureOrganPathogenesisPlayPopulationProbabilityProductionProteinsReportingRoleSignal TransductionSkinSmall Interfering RNASolidSourceStimulusSurfaceSymptomsTSLP geneTestingTransfectionTranslatingUnited StatesUrticariaVirusWorkanti-IgEcell typechemical releaseclinically relevantcrosslinkcytokineexperiencegranulocytein vivoinnovationinsightknock-downmouse modelnovelomalizumabresearch studyresponseskin disorderstemsugar
项目摘要
ABSTRACT
Allergic diseases are caused by inappropriate immune responses to otherwise harmless
antigens, and, in one form or another, affect up to 25% of the population in the United States, with a
disproportionate increase especially among children with asthma and food-related hypersensitivities.
While many immune cell types are implicated in the pathogenesis of allergic disease there is growing
evidence that basophil granulocytes play a far greater role than initially thought. Indeed, a good
portion of this excitement stems from work done ~20 years ago (including our own) showing that
human basophils are a prolific source of IL-4 & IL-13 –cytokines central to the allergic diathesis. More
recently, these findings have been confirmed and extended in vivo using mouse models. Moreover,
some mouse models now show evidence of an “axis” whereby epithelial cell (EC)-derived cytokines
(e.g. TSLP, but also IL-33 and IL-25) activate basophils to produce IL-4 (& IL-13) that is seemingly
critical for initiating IgE synthesis and thus sensitization. In contrast, confirmatory results identifying
TSLP as an activator of human basophils have not been forthcoming. In exploring this translational
discrepancy, we have now uncovered a remarkably robust, and potentially unique, mode of EC-
dependent activation of human basophils that occurs independently of known EC-derived cytokines.
Basophils co-cultured with EC of lung origin (A549 cells) in the presence of IL-3 secrete high IL-4/IL-
13 levels yet to be achieved with other modes of stimulation. This response is preceded by mediator
(histamine) release, but with delayed kinetics compared to that seen with standard FcεRI-dependent
activation. New evidence points to an IgE-binding protein on EC (e.g. galectin-3) that is mediating this
unique mode of basophil activation. Two aims are proposed to further characterize this novel
response. Aim 1 explores the nature of this interaction, hypothesizing the need for cell-to-cell
interactions. The role of IL-3 priming of basophils and the requirement for IgE are also to be
investigated. We proposed experiments also testing whether EC activate other IgE-bearing cells (e.g.
mast cells) for similar activity. And, other EC lines (including normal EC) are to be investigated for
mediating basophil activation, hypothesizing that “danger signals” (viruses, cytokines, TLR agonists)
play an important role in enabling the latter to possess a similar capacity. Aim 2 studies are to explore
the role of known IgE-binding proteins such as galectin-3 (but also CD23b, and potentially novel ones),
in meditating this activity. Overall, our unique experience working with human basophils makes this
R21 application highly innovative, and increases the probability that novel, significant, and clinically
relevant findings will be discovered.
摘要
过敏性疾病是由不适当的免疫反应引起的,
抗原,并且以一种或另一种形式影响美国高达25%的人口,
特别是在患有哮喘和与食物有关的过敏症的儿童中。
虽然许多免疫细胞类型与过敏性疾病的发病机制有关,但越来越多的免疫细胞类型被发现与过敏性疾病有关。
嗜碱性粒细胞发挥的作用比最初认为的要大得多。的确,
这种兴奋的一部分源于20年前(包括我们自己)所做的工作,
人嗜碱性粒细胞是IL-4和IL-13 -细胞因子的丰富来源,这些细胞因子对变应性素质至关重要。更
最近,这些发现已被证实,并在体内扩大使用小鼠模型。此外,委员会认为,
一些小鼠模型现在显示出“轴”的证据,
(e.g. TSLP,还有IL-33和IL-25)激活嗜碱性粒细胞产生IL-4(和IL-13),这似乎是
对于启动IgE合成并因此致敏至关重要。相比之下,确认结果表明,
TSLP作为人类嗜碱性粒细胞的激活剂尚未出现。在探索这种翻译
差异,我们现在已经发现了一个非常强大的,潜在的独特的,EC模式-
人嗜碱性粒细胞的依赖性活化,其独立于已知的EC衍生的细胞因子而发生。
在IL-3存在下与肺源EC(A549细胞)共培养的嗜碱性粒细胞分泌高IL-4/IL-
13个水平尚未达到与其他模式的刺激。此响应之前是调解人
(组胺)释放,但与标准Fcε RI依赖性
activation.新的证据指出EC上的IgE结合蛋白(例如半乳糖凝集素-3)介导了这一过程。
嗜碱性粒细胞激活的独特模式。两个目标提出进一步表征这部小说
反应目的1探讨了这种相互作用的性质,假设需要细胞对细胞的相互作用。
交互.嗜碱性粒细胞的IL-3引发作用和对IgE的需求也有待进一步研究。
研究了我们提出的实验也测试EC是否激活其他携带IgE的细胞(例如,
肥大细胞)的相似活性。并且,将调查其他EC线(包括正常EC),
介导嗜碱性粒细胞活化,假设“危险信号”(病毒、细胞因子、TLR激动剂)
在使后者拥有类似能力方面发挥重要作用。目的2研究旨在探索
已知的IgE结合蛋白如半乳糖凝集素-3(还有CD 23 b,以及潜在的新蛋白)的作用,
冥想这个活动。总的来说,我们与人类嗜碱性粒细胞合作的独特经验使得
R21应用高度创新,并增加了新的,重要的,临床上
将发现相关发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN T. SCHROEDER其他文献
JOHN T. SCHROEDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN T. SCHROEDER', 18)}}的其他基金
Galectins in Modulating Immune Responsiveness of IgE-bearing Cells
半乳糖凝集素调节 IgE 细胞的免疫反应
- 批准号:
10651597 - 财政年份:2019
- 资助金额:
$ 24.3万 - 项目类别:
Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
- 批准号:
8424318 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
- 批准号:
8241529 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Basophils in Modulating Th2 Responses in Human Allergic Disease
嗜碱性粒细胞调节人类过敏性疾病中的 Th2 反应
- 批准号:
8308732 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Innate Immune Function of FcERI-Bearing Cells
携带 FcERI 的细胞的先天免疫功能
- 批准号:
7150228 - 财政年份:2006
- 资助金额:
$ 24.3万 - 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
- 批准号:
6856521 - 财政年份:1998
- 资助金额:
$ 24.3万 - 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
- 批准号:
7191604 - 财政年份:1998
- 资助金额:
$ 24.3万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Research Grant